Inhalatives Budesonid zur Therapie bei COVID-19
Standard
Inhalatives Budesonid zur Therapie bei COVID-19. / Kluge, S; Nitschmann, S; Scherer, M.
In: INTERNIST, Vol. 62, No. 8, 08.2021, p. 887-889.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Inhalatives Budesonid zur Therapie bei COVID-19
AU - Kluge, S
AU - Nitschmann, S
AU - Scherer, M
PY - 2021/8
Y1 - 2021/8
U2 - 10.1007/s00108-021-01071-4
DO - 10.1007/s00108-021-01071-4
M3 - SCORING: Zeitschriftenaufsatz
C2 - 34191054
VL - 62
SP - 887
EP - 889
JO - INTERNIST
JF - INTERNIST
SN - 0020-9554
IS - 8
ER -